Symeres Welcomes Jurgen Berendsen as Chief Financial Officer

Symeres, a contract research, development, and manufacturing organization (CRDMO), has announced the appointment of Jurgen Berendsen as Chief Financial Officer (CFO), marking a return to the company after a successful tenure as Senior Group Controller.

Berendsen brings more than 15 years of financial leadership experience across both professional services and international trade sectors, including time at KPMG, Hoogwegt International, and most recently Royal Reesink, where he served as Vice President of Finance and Control. Berendsen brings not only deep institutional knowledge, but also an external perspective gained from leading finance functions in other complex organizations.

“Jurgen’s appointment comes at a critical moment for Symeres as we strengthen our operational and financial foundations to scale more effectively,” said Guillaume Jetten, CEO of Symeres. “He combines strategic vision with a deep understanding of our business and culture. His return brings continuity and a partner mindset that will benefit the whole organization.”

About Berendsen

Berendsen previously joined Symeres in 2022 to take on the newly created role of Group Financial Controller. During his time at the company, he played a key role in the implementation of major transformation programs, including finance systems (ERP) upgrades, compliance initiatives, and business continuity planning. His close collaboration with the board and hands-on approach during the company’s restructuring phase earned him wide respect across the organization.

In his new role, Berendsen will oversee financial operations across Symeres’ global footprint, working closely with the executive team to support sustainable growth. His focus will be on building financial resilience, driving operational integration across sites in the Netherlands, Finland, and the U.S., and championing transparency and trust, both internally and with clients.

“Returning to Symeres as CFO is an extremely exciting opportunity,” said Jurgen Berendsen. “Symeres has all the ingredients for long-term growth and success. I am proud to join a strong and dedicated leadership team who is unwaveringly committed to delivering optimal outcomes for customers, employees, and shareholders alike.”

More Symeres News

Last year, Symeres acquired DGr Pharma, a drug development-focused consultancy, to expand its integrated early-stage drug development services and accelerate IND-enabling capabilities for biopharma clients.